Table 7.
Percentage of hearts presenting LVNC in isomerism according to Chin, Jenni, and Petersen (apex).
Chin | Jenni | Petersen | |||||||
---|---|---|---|---|---|---|---|---|---|
CHD | % (n) | OR * (95% CI) | p-Value | % (n) | OR * (95% CI) | p-Value | % (n) | OR * (95% CI) | p-Value |
isolated isomerism | 0.0% (0/3) | - | - | 0.0% (0/3) | - | - | 0.0% (0/3) | - | - |
isomerism + ASD | 0.0% (0/4) | 0.78 (0.01–49.95) | 1.0000 | 0.0% (0/4) | 0.78 (0.01–49.95) | 1.0000 | 0.0% (0/4) | 0.78 (0.01–49.95) | 1.0000 |
isomerism + ASD + VSD | 20.0% (1/5) | 2.33 (0.70–76.73) | 1.0000 | 20.0% (1/5) | 2.33 (0.70–76.73) | 1.0000 | 20.0% (1/5) | 2.33 (0.70–76.73) | 1.0000 |
isomerism + AVSD | 0.0% (0/8) | 0.41 (0.01–25.19) | 1.0000 | 0.0% (0/8) | 0.41 (0.01–25.19) | 1.000 | 0.0% (0/8) | 0.41 (0.01–25.19) | 1.0000 |
other combinations | 11.1% (1/9) | 1.23 (0.04–38.33) | 1.0000 | 11.1% (1/9) | 1.23 (0.04–38.33) | 1.0000 | 11.1% (1/9) | 1.23 (0.04–38.33) | 1.0000 |
* Odds ratio (OR) versus isolated isomerism.